WASHINGTON, D.C. — In response to Senate Majority Leader Chuck Schumer’s (D-N.Y.) drug pricing scheme, Adam Brandon, FreedomWorks President, commented:
“Yet another socialist drug pricing scheme has found its way into the halls of Congress. Like other countries that have socialist drug price controls, the unintended consequence of implementing this policy in the U.S. is that it would limit access to new medicines and treatments.
“Prices signal what something is worth; merely dictating that prices are different will not solve the underlying issue. We should encourage market competition from low-cost generics and biosimilars to reduce patient costs.
“Make no mistake; this policy proposal does not have patients’ best interests at heart. It will only harm patients, stifle innovation, and create scarcity.”
The mission of FreedomWorks is to build, educate, and mobilize the largest network of activists advocating the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law.